At a glance
ClinicalIndex Comparison RecordN/ACompleted· 175 enrolled
Drug / intervention
Restylane Lyft with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
In Brief
A clinical study evaluating Restylane Lyft with Lidocaine and Juvederm Voluma XC for Chin Augmentation and Chin Retrusion. Completed, enrolled 175 participants across 12 sites in 2 countries.
Detailed Summary
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChin Augmentation, Chin Retrusion
CountriesPuerto Rico, United States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedMar 2023
Enrollment StartMar 2023
Primary CompletionNov 2023
Study CompletionJul 2024
TodayJul 2026
First PostedMar 21, 2023
Enrollment StartMar 22, 2023
Primary CompletionNov 11, 2023
Study CompletionJul 10, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.3 years ago
Interventions
Restylane Lyft with Lidocainedevice
hyaluronic acid
Juvederm Voluma XCdevice
hyaluronic acid